During the past decade, Spitalul Clinic de Boli Infectioase "Sfanta Parascheva" conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" #1 sponsor was "Pfizer" with 2 trials, followed by "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "MJM Bonten" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Da Volterra" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator and "Syneos Health, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" are "COVID-19" (1 trials), "Carbapenem Resistant Bacteria Infection" (1 trials), "Clostridioides Difficile Infection" (1 trials), "Clostridium Difficile" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" are "Drug" (6 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATM-AVI" (2 trials), "Placebo" (2 trials), "BAT" (1 trials), "Baloxavir Marboxil" (1 trials) and "COL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Clinic de Boli Infectioase "Sfanta Parascheva"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Spitalul Clinic de Boli Infectioase "Sfanta Parascheva", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic de Boli Infectioase "Sfanta Parascheva", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".